Do you want to read an article? Please log in or register.
Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the COSYCONET cohort
COPD
RECOMMENDED
Related content
RECOMMENDED
COPD
The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Res.
Kahnert K, Föhrenbach M, Lucke T, Alter P, Trudzinski FT, Bals R, Lutter JI, Timmermann H, Söhler S, Förderreuther S, Nowak D, Watz H, Waschki B, Behr J, Welte T, Vogelmeier CF, Jörres RA
doi: 10.1186/s12931-020-1293-6.
RECOMMENDED
COPD
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study
Lancet Respir Med.
Suissa S, Dell'Aniello S, Ernst P
doi: 10.1016/S2213-
RECOMMENDED
Asthma
Newborn DNA-methylation, childhood lung function, and the risks of asthma and COPD across the life course
Eur Respir J.
den Dekker HT, Burrows K, Felix JF, Salas LA, Nedeljkovic I, Yao J, Rifas-Shiman SL, Ruiz-Arenas C, Amin N, Bustamante M, DeMeo DL, John Henderson A, Howe CG, Hivert MF, Arfan Ikram M, de Jongste JC, Lahousse L, Mandaviya PR, van Meurs JB, Pinart M, Sharp GC, Stolk L, Uitterlinden AG, Anto JM, Litonjua AA, Breton CV, Brusselle GG, Sunyer J, Smith GD, Relton CL, Jaddoe VWV, Duijts L
doi: 10.1183/13993003.
COPD
Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort
Ann Am Thorac Soc.
Martinez CH, Murray S, Barr RG, Bleecker E, Bowler RP, Christenson SA, Comellas AP, Cooper CB, Couper D, Criner GJ, Curtis JL, Dransfield MT, Hansel NN, Hoffman EA, Kanner RE, Kleerup E, Krishnan JA, Lazarus SC, Leidy NK, O'Neal W, Martinez FJ, Paine R 3rd, Rennard SI, Tashkin DP, Woodruff PG, Han MK; Subpopulations and Intermediate Outcome Measures in COPD Study Investigators
doi: 10.1513/
RECOMMENDED
COPD
Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials
J Antimicrob Chemother.
Wang Y, Zijp TR, Bahar MA, Kocks JWH, Wilffert B, Hak E
doi: 10.1093/jac/dky326.
COMMENTED
COPD
Associations between 25-hydroxy-vitamin D levels, lung function, and exacerbation outcomes in COPD: An analysis of the SPIROMICS cohort
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Chest.
Burkes RM, Ceppe AS, Doerschuk CM, Couper D, Hoffman EA, Comellas AP, Barr RG, Krishnan JA, Cooper C, Labaki WW, Ortega VE, Wells JM, Criner GJ, Woodruff PG, Bowler RP, Pirozzi CS, Hansel NN, Wise R, Brown TT, Drummond MB, SPIROMICS Investigators
doi: 10.1016/j.chest.2019.11.047.
RECOMMENDED
COPDPneumonia
Real world effects of COPD medications: a cohort study with validation against RCT results
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J.
Wing K, Williamson E, Carpenter JR, Wise L, Schneeweiss S, Smeeth L, Quint JK, Douglas I
doi: 10.1183/13993003.01586-2020. Visit the original publication at ncbi.nlm.nih.gov
RECOMMENDED
COPD
Association between COPD exacerbations and lung function decline during maintenance therapy
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Thorax.
Kerkhof M, Voorham J, Dorinsky P, Cabrera C, Darken P, Kocks JW, Sadatsafavi M, Sin DD, Carter V, Price DB
doi: 10.1136/thoraxjnl-2019-214457.
RECOMMENDED
COPD
Accelerated epigenetic aging as a risk factor for chronic obstructive pulmonary disease and decreased lung function in two prospective cohort studies
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Aging (Albany NY).
Breen M, Nwanaji-Enwerem JC, Karrasch S, Flexeder C, Schulz H, Waldenberger M, Kunze S, Ollert M, Weidinger S, Colicino E, Gao X, Wang C, Shen J, Just AC, Vokonas P, Sparrow D, Hou L, Schwartz JD, Baccarelli AA, Peters A, Ward-Caviness CK
doi: 10.18632/aging.103784.